ARTICLES BY THIS AUTHOR
- 5/31/2012
Atrial fibrillation guidelines: 2012 update
Update incorporates new evidence on stroke prevention and rate and rhythm control. - 5/31/2012
Drug News: June 2012
Fampyra to improve walking speed in MS; Lodalis for hypercholestrerolemia; Saphris atypical antipsychotic; Other new products (Arzerra, Durela, Luxiq, Mozobil and Zelboraf); new generics, new indications, new dosage forms and Health Canada advisories. - 5/31/2012
CADTH Corner: Understanding generic drugs
CADTH has created a series of tools to help you understand and explain the facts about generic drugs. - 5/31/2012
Bedbugs: Prevention, treatment, and public education
Prevention, eradication, and treatment measures and the educational role of pharmacists in maintaining patient well being. - 5/31/2012
Tech Refresher: A prescription for medication safety
Pharmacy technicians and assistants have a critical role to play in medication safety. - 5/31/2012
U.S. pharmacists cautiously optimistic about proposed “third class” of drugs
Under the FDA’s proposal, certain drugs that would otherwise require a prescription will be approved for nonprescription use under conditions of safe use. - 5/31/2012
The Medical Post table of contents: June 5, 2012 print edition
A section by section guide to content - 5/31/2012
Sue Paish leaves Pharmasave
Paish joined Pharmasave in 2004 as a director on the Board of Directors and was appointed CEO of the company in 2007. - 5/31/2012
Practice Issues: Best options for menstrual-related migraine
Q. Which drugs are effective and safe for treatment or prevention of menstrual-related migraine?